The fine art of the circular argument applied to management of prostate cancer

It will likely be evident to most well-informed prostate cancer patients, support group leaders, and advocates that a man with low-risk, early stage prostate cancer (“favorable histology”) is potentially a good candidate for prostate cancer surgery. … READ MORE …

Experience certainly improves technical skill at RALP

There has been a lot of media noise about a poster presented at the Genitourinary Cancer Symposium. The poster supposedly suggests that it takes 1,600 robot-assisted procedures (RALP) to be really good at this form of surgery. … READ MORE …

RALP as a treatment for prostate cancer in HIV-positive patients

A report from the University of California San Diego says that robot-assisted laparoscopic prostatectomy (RALP) appears to be a safe and effective treatment for localized prostate cancer in men who are HIV-positive but are taking highly active antiretroviral therapy (HAART) and have undetectable viral loads (< 50). … READ MORE …

5-year outcomes of patients treated with RALP at a high-volume, specialty center

There has been much discussion of whether surgical outcomes following robot-assisted laparoscopic prostatectomy (RALP) are comparable to those observed after open surgery. The 5-year outcome data from the Vattikuti Urology Institute at Henry Ford Hospital in Detroit may help us to make such a determination. … READ MORE …

Rapid increase in number of radical prostatectomies in the USA

Another article in this week’s New England Journal of Medicine addresses the rapid increase in the number of robot-assisted surgical procedures carried out in the US between 2005 and 2008. … READ MORE …

Prostate cancer news reports: Thursday, February 18, 2010

Today’s news reports include commentary on studies dealing with:

  • Whether RALP outcomes are really comparable to those from RRP
  • Surgical expertise, surgical caseload, and pelvic lymphadenectomy in treatment of intermediate- and high-risk prostate cancer
  • Sexual function after first-line treatment with SBRT (CyberKnife)
  • Distinguishing true biochemical recurrence from a PSA “bounce” after 125I-based prostate brachytherapy … READ MORE …

The marketing of RALP: 2002 to 2010

Many readers may be interested in an article by Gina Kolata in Saturday’s New York Times on the rapid uptake of robot-assisted laparoscopic prostatectomy (RALP) for the first-line treatment prostate cancer. … READ MORE …